Related Experiment Videos
Antibiotic biosynthesis by cofermentation of blocked mutants of two Micromonospora species
Abstract:
Two aminocyclitol-negative Micromonospora mutants representing two different species, M. purpurea and M. inyoensis, and blocked at different steps in the biosynthetic pathway were paired and cofermented for the synthesis of antibiotics. The two blocked mutants were incapable of producing antibiotics alone except when 2-deoxystreptamine was added. When combined they produced gentamicins A, X(2), C(1a), and C(2b), which all have an amino group at the 2' position, and gentamicin B, which has a hydroxyl group at this position instead.
Insights
Cofermenting Micromonospora mutants deficient in antibiotic production restored synthesis. Combining these blocked strains enabled the production of various gentamicin compounds, highlighting synergistic biosynthesis.
Area of Science:
- Microbiology
- Biochemistry
- Synthetic Biology
Background:
- Micromonospora species are known producers of bioactive compounds, including antibiotics.
- Biosynthetic pathways for complex molecules like gentamicin can be interrupted in mutant strains.
- Aminocyclitol-negative mutants of Micromonospora are unable to produce antibiotics independently.
Purpose of the Study:
- To investigate the potential of cofermentation of blocked Micromonospora mutants for antibiotic synthesis.
- To determine if combining different mutant strains can restore gentamicin production.
- To analyze the types of gentamicin compounds produced through this synergistic approach.
Main Methods:
- Utilized two aminocyclitol-negative Micromonospora mutants (M. purpurea and M. inyoensis) blocked at different biosynthetic steps.
- Paired and cofermented these mutant strains under specific conditions.
- Supplemented fermentation with 2-deoxystreptamine to assess its necessity for antibiotic production.
Main Results:
- Individually, the mutants could not produce antibiotics unless 2-deoxystreptamine was added.
- Cofermentation of the two distinct mutants successfully yielded a range of gentamicin compounds.
- The produced gentamicins included A, X(2), C(1a), and C(2b) (2'-amino group) and gentamicin B (2'-hydroxyl group).
Conclusions:
- Cofermentation of complementary blocked mutants can restore complex antibiotic biosynthesis.
- This approach demonstrates a method for generating diverse gentamicin variants.
- Synergistic interactions between microbial mutants can overcome metabolic blocks and enable production of valuable compounds.